Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 4/20 | 0.51 |
| ▸ | STAT3 | P40763 | 1/20 | 0.51 |
| ▸ | STAT1 | P42224 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 4/20 | 0.50 |
| ▸ | CYCS | P99999 | 3/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14080609 | 1.00 | TOP1 (0.51) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL14080379 | 1.00 | TOP1 (0.51) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL25395411 | 1.00 | TOP1 (0.51) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL432185 | 0.92 | KDM4E (0.46) | TOP1TERTHTTSMN1; SMN2 | |
| SCHEMBL29822398 | 0.92 | KDM4E (0.46) | TOP1TERTHTTSMN1; SMN2 | |
| SCHEMBL18795854 | 0.91 | TOP1 (0.52) | TOP1STAT3STAT1TERTCYCS | |
| SCHEMBL29560659 | 0.90 | KDM4E (0.45) | TOP1TERTHTTSMN1; SMN2 | |
| SCHEMBL9418754 | 0.90 | KDM4E (0.45) | TOP1TERTHTTSMN1; SMN2 | |
| SCHEMBL601668 | 0.90 | KDM4E (0.45) | TOP1TERTHTTSMN1; SMN2 | |
| SCHEMBL599851 | 0.90 | KDM4E (0.45) | TOP1TERTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | FUJIFILM CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | FUJIFILM CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| EP-2346875-B1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | CENTRE NAT RECH SCIENT (FR) | 2014-03-19 | — | — | EP | disclosed |
| US-8633123-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-8633123-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-8425879-B2 | Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-04-23 | — | — | US | disclosed |
| US-20110262357-A1 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-10-27 | — | — | US | disclosed |
| EP-2346875-A1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | Centre National de la Recherche Scientifique (FR) | 2011-07-27 | — | — | EP | disclosed |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2010080881-A1 | SUBSTITUTED PORPHYRINS | DUKE UNIVERSITY (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010029232-A1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262357-A1 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy | PPOX, PPIF, PPIL4 | TOP1 2238/4885STAT3 1128/4885STAT1 1570/4885 |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | CA3, NIT2, NOX3 | TOP1 2153/4885STAT3 2514/4885STAT1 4506/4885 |
| US-20110152497-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | TOP1 858/4885STAT3 4001/4885STAT1 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.